These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 15851228)

  • 1. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter.
    Hothi SS; Ara F; Timperley J
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):93-7. PubMed ID: 24903439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family.
    Kyndt F; Probst V; Potet F; Demolombe S; Chevallier JC; Baro I; Moisan JP; Boisseau P; Schott JJ; Escande D; Le Marec H
    Circulation; 2001 Dec; 104(25):3081-6. PubMed ID: 11748104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3.
    Weiss R; Barmada MM; Nguyen T; Seibel JS; Cavlovich D; Kornblit CA; Angelilli A; Villanueva F; McNamara DM; London B
    Circulation; 2002 Feb; 105(6):707-13. PubMed ID: 11839626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome.
    Baroudi G; Napolitano C; Priori SG; Del Bufalo A; Chahine M
    Can J Cardiol; 2004 Mar; 20(4):425-30. PubMed ID: 15057319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation.
    Probst V; Allouis M; Sacher F; Pattier S; Babuty D; Mabo P; Mansourati J; Victor J; Nguyen JM; Schott JJ; Boisseau P; Escande D; Le Marec H
    J Cardiovasc Electrophysiol; 2006 Mar; 17(3):270-5. PubMed ID: 16643399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double SCN5A mutation underlying asymptomatic Brugada syndrome.
    Yokoi H; Makita N; Sasaki K; Takagi Y; Okumura Y; Nishino T; Makiyama T; Kitabatake A; Horie M; Watanabe I; Tsutsui H
    Heart Rhythm; 2005 Mar; 2(3):285-92. PubMed ID: 15851320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.
    Itoh H; Shimizu M; Mabuchi H; Imoto K
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients.
    Smits JP; Eckardt L; Probst V; Bezzina CR; Schott JJ; Remme CA; Haverkamp W; Breithardt G; Escande D; Schulze-Bahr E; LeMarec H; Wilde AA
    J Am Coll Cardiol; 2002 Jul; 40(2):350-6. PubMed ID: 12106943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease.
    Neu A; Eiselt M; Paul M; Sauter K; Stallmeyer B; Isbrandt D; Schulze-Bahr E
    Hum Mutat; 2010 Aug; 31(8):E1609-21. PubMed ID: 20564468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic analysis of Brugada syndrome in Israel: two novel mutations and possible genetic heterogeneity.
    Levy-Nissenbaum E; Eldar M; Wang Q; Lahat H; Belhassen B; Ries L; Friedman E; Pras E
    Genet Test; 2001; 5(4):331-4. PubMed ID: 11960580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrocardiogram changes and atrial arrhythmias in individuals carrying sodium channel SCN5A D1275N mutation.
    Vanninen SUM; Nikus K; Aalto-Setälä K
    Ann Med; 2017 Sep; 49(6):496-503. PubMed ID: 28294644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope.
    Makita N; Sumitomo N; Watanabe I; Tsutsui H
    Heart Rhythm; 2007 Apr; 4(4):516-9. PubMed ID: 17399644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization.
    Watanabe H; Nogami A; Ohkubo K; Kawata H; Hayashi Y; Ishikawa T; Makiyama T; Nagao S; Yagihara N; Takehara N; Kawamura Y; Sato A; Okamura K; Hosaka Y; Sato M; Fukae S; Chinushi M; Oda H; Okabe M; Kimura A; Maemura K; Watanabe I; Kamakura S; Horie M; Aizawa Y; Shimizu W; Makita N
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):874-81. PubMed ID: 22028457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads.
    Potet F; Mabo P; Le Coq G; Probst V; Schott JJ; Airaud F; Guihard G; Daubert JC; Escande D; Le Marec H
    J Cardiovasc Electrophysiol; 2003 Feb; 14(2):200-3. PubMed ID: 12693506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.
    Turker I; Makiyama T; Vatta M; Itoh H; Ueyama T; Shimizu A; Ai T; Horie M
    PLoS One; 2016; 11(8):e0161872. PubMed ID: 27560382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.